UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040996
Receipt number R000046812
Scientific Title A Study on the Effect of Food Containing Plant Extract on the Alleviation of the Symptom of a Hangover on the Next Day of Drinking
Date of disclosure of the study information 2020/07/05
Last modified on 2021/10/26 14:32:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effect of Food Containing Plant Extract on the Alleviation of the Symptom of a Hangover on the Next Day of Drinking

Acronym

A Study on the Effect of Food Containing Plant Extract on the Alleviation of the Symptom of a Hangover on the Next Day of Drinking

Scientific Title

A Study on the Effect of Food Containing Plant Extract on the Alleviation of the Symptom of a Hangover on the Next Day of Drinking

Scientific Title:Acronym

A Study on the Effect of Food Containing Plant Extract on the Alleviation of the Symptom of a Hangover on the Next Day of Drinking

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy of food containing plant extract on the symptom of a hangover

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Questionnaires on a hangover

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Food containing low-dose plant extract, single ingestion

Interventions/Control_2

Food containing high-dose plant extract, single ingestion

Interventions/Control_3

Food not containing plant extract, single ingestion

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

(1) Males aged 30 to 59 years-old.
(2) Subjects who are healthy and are not suffered from chronic disease.
(3) Subjects who can take alcohol (ND type or NN type in the alcohol patch test), and are likely to have a hangover the next day.
(4) Subjects who can make self-judgment and are voluntarily giving written informed consent.
(5) Subjects who can have an examination on a designated check day.
(6) Subjects who are judged as suitable for the current study by the investigator.

Key exclusion criteria

(1) Subjects with DD type in the alcohol patch test.
(2) Subjects who have never had a hangover.
(3) Subjects who have excessive alcohol intake more than 60 g/day of pure alcohol equivalent.
(4) Subjects who contract disease and are under treatment.
(5) Subjects who have a history of and/or contract serious diseases (eg, hyperlipidemia, high blood pressure, diabetes, psychiatric disease, sleeping disorder ).
(6) Subjects who used a drug to treat a disease in the past 1 month (except temporal usage for headache and cold).
(7) Subjects who have a history of and/or contract serious diseases (eg, liver disease, kidney disease, heart disease, lung disease, blood disease).
(8) Subjects who have a history and/or contract digestive disease (except disease of an appendix).
(9) Subjects whose BMI are under 18.5 or 30 or more.
(10) Subjects with serious anemia.
(11) Subjects who have allergic reaction to ingredients of test foods and other foods or drugs.
(12) Subjects with possible changes of life style, such as a long-term travel and a late-night shift, during test periods.
(13) Subjects who have a habit to use Foods with Function Claims, functional foods and/or supplements claiming to improve liver function (curcumin, clam extract, liver extract, etc.) in the past 3 months and/or are planning to use those foods during test periods.
(14) Subjects who have difficulty in taking meals (dinner and lunch on the inspection day).
(15) Subjects who are participating and/or had participated in other clinical studies within the last three months prior to the current study.
(16) Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

42


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Kondo

Organization

Medical Corporation Meiseikai, Higashi Shinjuku Clinic

Division name

Director

Zip code

169-0072

Address

3F Daito Bldg. 1-11-3 Okubo Shinjuku-ku Tokyo 169-0072, JAPAN

TEL

+81-3-6233-8583

Email

h.kondo@meiseikai-cl.com


Public contact

Name of contact person

1st name Ryoma
Middle name
Last name Shimizu

Organization

TES Holdings Co., Ltd.

Division name

Administrative Department of Clinical Trials

Zip code

110-0015

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

TEL

+81-3-6801-8480

Homepage URL


Email

r.shimizu@tes-h.co.jp


Sponsor or person

Institute

TES Holdings Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

Tel

+81-3-6240-1162

Email

jimukyoku@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 05 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000046812

Publication of results

Published


Result

URL related to results and publications

http://www.pieronline.jp/content/article/0386-3603/49060/965

Number of participants that the trial has enrolled

42

Results

Statistically significant difference was confirmed in the primary outcome.

Results date posted

2021 Year 10 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Males and females aged 30 to 59 years old.

Participant flow

Enrolled(n=42)
Completed(n=39)
Analysed(n=34)

Adverse events

No adverse events were observed that be related to test food.

Outcome measures

Questionnaires on a hangover

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 06 Month 23 Day

Date of IRB

2020 Year 06 Month 24 Day

Anticipated trial start date

2020 Year 07 Month 06 Day

Last follow-up date

2020 Year 08 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 03 Day

Last modified on

2021 Year 10 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046812


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name